Bioxytran
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $3,820,147.

Profit Margin

Bioxytran, Inc. (OTC:BIXT): Profit margin
2014 275.61K -1.34M -488.69%
2015 255.82K -2.10M -820.93%
2016 246.49K -696.75K -282.67%
2017 191.07K -318.38K -166.63%
2018 0 -296.41K
2019 0 -2.08M
2020 0 -3.75M
2021 0 -4.34M
2022 0 -2.46M
2023 0 -4.28M

BIXT Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
000000191.07K246.49K255.82K275.61K
Cost of revenue
8.28K3.64K0000103.97K96.30K135.68K165.97K
Gross profit
-8.28K-3.64K000087.09K150.19K120.13K109.63K
Operating exp.
Research and development
1.14M977.76K2.01M544.51K000000
Selling and marketing
197.55K000000000
Total operating expenses
3.82M2.13M4.21M1.26M1.63M214.71K397.68K821.47K2.21M1.39M
Operating income
-3.82M-2.13M-4.21M-1.26M-1.63M-214.71K-310.58K-671.27K-2.09M-1.28M
Other income (expenses), net
-550.11K-523.19K-313.60K-1.27M-227.00K-81.30K-7.8K-17.67K-7.8K-66.19K
Income before tax
-4.37M-2.65M-4.52M-2.54M-1.85M-296.01K-318.38K-696.75K-2.10M-1.34M
Income tax expense
0-193.37K-182.68K1.21M227.00K4007.8K25.47K7.8K66.19K
Net income
-4.28M-2.46M-4.34M-3.75M-2.08M-296.41K-318.38K-696.75K-2.10M-1.34M
Earnings per share
Basic EPS
-0.03-0.02-0.04-0.04-0.02-0.00-0.24-0.79-6.25-9.07
Diluted EPS
-0.03-0.02-0.04-0.04-0.02-0.00-0.24-0.79-6.25-9.07
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source